Newly established firm puts down roots in Denmark
US pharmaceutical company MSD has established a spinout company, Organon, which will have an office in Copenhagen. Organon focuses on women's health.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY CATHERINE BRETT AND DANIEL FRANK CHRISTENSEN
Pharmaceutical group MSD, known as Merck in the US and Canada, has now officially launched its spinout company Organon. It will have offices all over the world, including in Copenhagen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Covid-19 costs Coloplast USD 33m in extended court cases
For subscribers
FDA grants new Genmab drug priority review status
For subscribers
Coloplast recalls urology product
For subscribers
